| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |